Author： Ni Ling-Na
Publisher： Humana Press, Inc
ISSN： 1357-0560
Source： Medical Oncology, Vol.28, Iss.1, 2011-03, pp. : 265-269
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
慢性髓细胞白血病对伊马替尼产生耐药性的机制 Imatinib Resistance Mechanism on Chronic Myeloid Leukemia
World Journal of Cancer Research, Vol. 02, Iss. 03, 2012-07 ,pp. :
Access to resources
Recommend
By Seong S. J. Lim M. Sohn S. K. Moon J. H. Oh S.-J. Kim B. S. Ryoo H. M. Chung J. S. Joo Y. D. Bang S. M. Jung C. W. Kim D. H. Park S. Y. Yoon S. S. Kim I. Lee H. G. Won J. H. Min Y. H. Cheong J. W. Park J. S. Eom K. S. Hyun M. S. Kim M. K. Kim H. Park M. R. Park J. Kim C. S. Kim H. J. Kim Y. K. Park E. K. Zang D. Y. Jo D. Y. Lee H. W. Yoon Y.-R.
Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. :
Access to resources
Imatinib and chronic myeloid leukemia: close to the bone
Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. :